Ms. Miller’s expertise in quality systems development, quality systems management, auditing, and MDD Compliance for all classes of medical device will bring great value to our clients. We are very pleased to welcome her to NDA Partners.
ROCHELLE, Va. (PRWEB) June 12, 2019
NDA Partners Chairman Carl Peck, MD, announced today that Andrea Miller, a quality assurance expert with more than 25 years of experience in quality systems development, quality systems management, auditing, FDA QSR/GMP, ISO 13485/9001, and MDD Compliance for all classes of medical devices, has joined NDA Partners as an Expert Consultant. Her experience includes quality systems development and management for OEM manufacturers, start-up device organizations, and contract manufacturing organizations.
Prior to joining NDA Partners, Ms. Miller was Quality Assurance Director at Paragon Vision Sciences and Director of Quality Assurance at EPIC Research & Diagnostics, Inc. She also served as Quality Assurance and Regulatory Manager of Polymicro Technologies (a division of Molex); National Compliance Manager of the Rural Metro Corporation (Scottsdale, AZ); Quality Improvement Manager at Regentek (a division of dj Orthopedics, LLC); and Senior Quality Engineer at IMPRA (a subsidiary of CR Bard).
“Ms. Miller’s expertise in quality systems development, quality systems management, auditing, and MDD Compliance for all classes of medical device will bring great value to our clients. We are very pleased to welcome her to NDA Partners,” said Dr. David Feigal.
Ms. Miller received her Bachelor of Science degree in Microbiology from Arizona State University and CQE Certification from the American Society for Quality.
About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Earle Martin, Chief Executive Officer